Sponsor:
Abramson Cancer Center at Penn Medicine
Code:
NCT05612789
Conditions
Allogeneic Transplantation
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Interventions
Exercise Program (Cohort A Prehab)
Exercise Program (Cohort B Rehab)
Brief summary:
Conditions
Allogeneic Transplantation
Study ID
NCT05612789
Start date
Feb 15, 2023
Status verified date
Dec, 2025
Completion date
Jun 1, 2031
Anticipated
Primary completion date
Jun 1, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Enrollment
72 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Cohort A (Prehab)
experimental: Cohort B (Rehab)
Interventions
Exercise Program (Cohort A Prehab)
Exercise Program (Cohort B Rehab)
Primary outcome measure
Central contacts
Locations
Penn Medicine
Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contacts
Sponsor
Abramson Cancer Center at Penn Medicine
Last update posted
Dec 10, 2025
Last verified
Dec, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Abramson Cancer Center at Penn Medicine on 2025-12-10.